Musculoskeletal
0 drugs are in development for Ankylosing Spondylitis.
- Companies
- 0
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Ankylosing Spondylitis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Ankylosing Spondylitis context
Musculoskeletal·MeSH: Spondylitis, Ankylosing (D013167)
Also known as: Ankylosing Spondylarthritides, Ankylosing Spondyloarthritides, Bechterew Disease, Bechterews Disease, Marie Struempell Disease, Spondylarthritis Ankylopoietica, Spondylarthritis, Ankylosing, Spondylitis Ankylopoietica, Spondylitis, Rheumatoid, Spondyloarthritis Ankylopoietica, Spondyloarthritis, Ankylosing
Prevalence
310.0 / 100K
Incidence
7.3 / 100K/yr
Frequently asked questions
How many clinical trials target Ankylosing Spondylitis?
There are 8 clinical trials targeting Ankylosing Spondylitis tracked by BioSniper.
What is the prevalence of Ankylosing Spondylitis?
The estimated prevalence of Ankylosing Spondylitis is approximately 310.0 per 100,000 population.